Immunosequencing identifies signatures of T cell responses for early detection of nasopharyngeal carcinoma

T cells in blood correlates with the infiltration of non-exhausted T cell counterparts in tumors and predicts prolonged survival, suggesting that these NPC-enriched T cells have significant potential for disease monitoring and therapeutic applications.